PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 1, 2004Expert Review of Cardiovascular Therapy

Clinical application of enoxaparin

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does enoxaparin improve clinical outcomes and safety compared to unfractionated heparin in patients requiring anticoagulation?

Population

Patients requiring anticoagulation across various clinical settings, including general, cancer, orthopedic…

Comparison

Enoxaparin (low-molecular-weight heparin) vs Unfractionated heparin or combination of UFH and…

Design

Review

Authors

THThomas Hofmann

Discussion

Loading...

Member takes

Overview

Supports enoxaparin convenience in ACS; leaves open need for updated RCTs to confirm outcomes in current practice.

Structured PICO

Does enoxaparin improve clinical outcomes and safety compared to unfractionated heparin in patients requiring anticoagulation?

P
Population
Patients requiring anticoagulation across various clinical settings, including general, cancer, orthopedic, or vascular surgery, severe cardiac disease, deep vein thrombosis, acute coronary syndromes, and atrial fibrillation undergoing electrical cardioversion
I
Intervention
Enoxaparin (low-molecular-weight heparin)
C
Comparator
Unfractionated heparin (UFH) or combination of UFH and phenprocoumone

Enoxaparin is a safe, effective, and cost-effective alternative to unfractionated heparin across a wide range of surgical and medical indications, offering the convenience of unmonitored and ambulatory administration.

Cite This Study

Thomas Hofmann (2004) studied this question.

synapsesocial.com/papers/6a2077a5d48e67d1607804fbhttps://doi.org/10.1586/14779072.2.3.321
View Full Paper
Ask AI
Bookmark
Share